InflaRx N.V. – Filings and Transcripts

NASDAQ: IFRX
Share price (11/10/26): $1.21
Market cap (11/10/26): $178 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Commodore Capital LP

Montanova Capital, LLC

Sirenia Capital Management LP

Farallon Capital Management, L.L.C.

News Filter

Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan

Highlights Izicopan Development Path and Commercial Opportunity in ANCA-Associated Vasculitis at Capital Markets Day

Unaudited Condensed Consolidated

Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026

Unaudited Condensed Consolidated

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness